Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
369.80
+21.80 (6.26%)
Last updated: Mar 5, 2026, 3:59 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceuticals
1.93B1.54B803.93M32.32M
Pharmaceuticals Growth
25.48%91.62%2387.26%-
Total
1.93B1.54B803.93M32.32M
Total Growth
25.48%91.62%2387.26%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
The PRC
92.65M7.54M56.49M20.39M
The PRC Growth
1128.18%-86.64%177.11%-
The United States of America
1.84B1.53B730.04M-
The United States of America Growth
20.43%109.33%--
Other Countries
-4.73M17.41M11.94M
Other Countries Growth
--72.85%45.83%-
Total
1.93B1.54B803.93M32.32M
Total Growth
25.48%91.62%2387.26%-
Source: S&P Global Market Intelligence.